Literature DB >> 3572445

Biopterins in arginase, dihydropteridine reductase and phenylalanine hydroxylase deficiency.

K Hyland, I Smith, J V Leonard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3572445      PMCID： PMC1031510          DOI： 10.1136/jnnp.50.2.242

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

1.  Arginase deficiency and phenylketonuria.

Authors:  P Cutler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

2.  Blood spots on Guthrie cards can be used for inherited tetrahydrobiopterin deficiency screening in hyperphenylalaninaemic infants.

Authors:  R J Leeming; P A Barford; J A Blair; I Smith
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

3.  Impaired neurotransmitter amine metabolism in arginase deficiency.

Authors:  K Hyland; I Smith; P T Clayton; J V Leonard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

4.  Estimation of tetrahydrobiopterin and other pterins in cerebrospinal fluid using reversed-phase high-performance liquid chromatography with electrochemical and fluorescence detection.

Authors:  D W Howells; I Smith; K Hyland
Journal:  J Chromatogr       Date:  1986-09-05

5.  Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by measurement of oxidized and reduced pterins in urine.

Authors:  S Milstien; S Kaufman; G K Summer
Journal:  Pediatrics       Date:  1980-04       Impact factor: 7.124

6.  Disturbed very long chain (C24-C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome.

Authors:  L Govaerts; J Bakkeren; L Monnens; J Maas; F Trijbels; W Kleijer
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

7.  Neurological aspects of biopterin metabolism.

Authors:  I Smith; R J Leeming; N P Cavanagh; K Hyland
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.